Vaso Corporation Sells VasoHealthcare IT to Nanox for Up to $800,000

Reuters2025-11-21
<a href="https://laohu8.com/S/VASO">Vaso Corporation</a> Sells VasoHealthcare IT to Nanox for Up to $800,000

Vaso Corporation has reached an agreement with Nano-X Imaging Ltd. to sell its subsidiary, VasoHealthcare IT Corp. The deal, valued at up to $800,000, includes $200,000 payable at closing and up to $600,000 as an earnout based on the business's post-closing performance. VasoHealthcare IT, which provides imaging information technology to hospitals and healthcare providers, represented less than 5% of Vaso's total revenue. The proceeds from the sale are expected to be used to invest in other business lines and strategic initiatives. The completion of the sale is anticipated within a few weeks, subject to certain conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaso Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-112966), on November 20, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment